Analyst Research Report Snapshot

Title:

AMPHION INNOVATIONS - PORTFOLIO ADVANCES

Price:

$10.00

Provider:

Edison Investment Research

Date:

11 Dec 2007

Pages:

12

Type:

AcrobatPDF

Companies referenced:

AMAMP.L

Available for Immediate Download
Summary:

Amphion reported an almost $5m rise in the value of its investment portfolio at the half-year point, and we expect further gains of over $10m in H2 based on completed fundraisings for Motif, Durham Scientific Crystals (DSC), Myconostica and WellGen. The remaining stake in Beijing Med-Pharm has been sold, and next year could see the first IPO of a Partner Company since Amphion’s own AIM listing. FOR MORE INFORMATION ON ATTACHED RESEARCH PLEASE CALL 020 7190 1755 OR EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.